GnRH receptor antagonists for prostate cancer.
GnRH receptor antagonists can reduce testosterone levels without the adverse reactions caused by other drugs used to treat prostate cancer. These drugs also offer hope for prolonged control of metastasis.
Medical University of South Carolina, Charleston, USA.
Emily
E
Patrick
Melissa
M
Whitson
Amy
A
Smith
Jamin
J
Parnell
Suzanne E
SE
Thomas
Clint C
CC
Blankenship
D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors* / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011966:Receptors, LHRH / Q000037:antagonists & inhibitors* / Q000627:therapeutic use*
D011966:Receptors, LHRH; D007987:Gonadotropin-Releasing Hormone